Edition:
United States

Moleculin Biotech Inc (MBRX.OQ)

MBRX.OQ on NASDAQ Stock Exchange Capital Market

1.78USD
1:12pm EDT
Change (% chg)

$0.04 (+2.30%)
Prev Close
$1.74
Open
$1.75
Day's High
$1.78
Day's Low
$1.74
Volume
10,593
Avg. Vol
41,765
52-wk High
$3.40
52-wk Low
$1.50

Chart for

About

Moleculin Biotech, Inc. is a preclinical-stage pharmaceutical company. The Company is focused on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, which it refers to as Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukemia (AML).... (more)

Overall

Beta: --
Market Cap(Mil.): $44.58
Shares Outstanding(Mil.): 25.77
Dividend: --
Yield (%): --

Financials

  MBRX.OQ Industry Sector
P/E (TTM): -- 28.87 33.05
EPS (TTM): -0.56 -- --
ROI: -55.29 13.59 13.17
ROE: -62.12 15.31 15.10

BRIEF-Moleculin Biotech Inc - Has Been Able To Show Promising Tumor Suppression Activity With Its Inhibitor Of Glycolysis, Wp1122

* MOLECULIN BIOTECH INC - HAS BEEN ABLE TO SHOW PROMISING TUMOR SUPPRESSION ACTIVITY WITH ITS INHIBITOR OF GLYCOLYSIS, WP1122 Source text for Eikon: Further company coverage:

Feb 07 2018

Earnings vs. Estimates